Skip to content

Study of expenditure on breast cancer treatment in women undergoing treatment at tertiary cancer center

Health expenditure on breast cancer treatment in women: a study from public sector tertiary cancer centre

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/07/020142
Enrollment
700
Registered
2019-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

None listed

Sponsors

Womens cancer initiative
Lead Sponsor
NAG foundation NGO
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) Pathologically confirmed new invasive breast cancer cases 2) Non-metastatic invasive breast cancer (AJCC 8th edition) 3) Intending to receive entire treatment at TMC 4) Planned for multi-modality treatment comprising of surgery, chemotherapy and radiotherapy with or without hormone therapy or targeted therapy 5) Age > 18 years 6) Patient willing to provide all estimates of expenditure before and after coming to the tertiary hospital. 7) Patient willing to share relevant socio-demographic information. 8) Willing to fill or respond to QOL instruments.

Exclusion criteria

Exclusion criteria: 1) Unable or unwilling to give written informed consent 2) Inability to follow up after treatment completion. 3) Not willing for follow up till 2 years. 4) Recurrent or progressive disease.

Design outcomes

Primary

MeasureTime frame
Estimation of direct cost and out of pocket (OOP) expenditure incurred by women for breast cancer treatment at public sector tertiary care hospital in India.Timepoint: After the last accrued patient completes entire treatment

Secondary

MeasureTime frame
1) Mean difference in expenditure in INR between two categories of patients (general and private) 2) Proportion of patients in each category experiencing catastrophic expenditure (expenditure exceeding 10% of household income) in different cohorts.Timepoint: After the last accrued patient completes the treatment

Countries

India

Contacts

Public ContactDr Tabassum Wadasadawala

Tata Memorial Hospital, Mumbai

twadasadawala@actrec.gov.in02227405079

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 11, 2026